Table 2.
Study (year) | Risk factor | Odds ratio (95% CI) | p-value | Participants | Comments | Ref. |
---|---|---|---|---|---|---|
Ohene-Frempong et al. (1998) | Steady-state Hb (for every 1 g/dl decrease) | 1.6 (1.1–2.4) | 0.013 | 2436 children and adults with HbSS | Did not report children and adults separately | [3] |
Steady-state leukocyte count for every 5000/μl increase) | 1.9 (1.7–2.2) | 0.026 | ||||
| ||||||
Strouse et al. (2009) | Hypertension | NC (1.7–NC) | <0.05 | 15 children with hemorrhagic and 29 with ischemic stroke | Case–control study | [12] |
Events in the last 14 days | ||||||
Transfusion of RBCs | 35 (4.9–289) | <0.001 | ||||
Corticosteroids | 20 (2.9–217) | <0.005 | ||||
NSAIDs | 4.4 (0.9–21) | <0.05 | ||||
| ||||||
Strouse et al. (2008) | Transfusion in last 14 days | 15 (1.5–708) | <0.01 | 20 adults with hemorrhagic and 29 with ischemic stroke | Case–control study | [17] |
| ||||||
Strouse et al. (2009) | Hypertension | 7.7 (4.7–13) | <0.0001 | 255 acute strokes among 69,586 discharges with sickle cell disease | Did not report children and adults separately | [7] |
Renal disease | 7.2 (3.4–14) | <0.0001 | ||||
Coagulopathy | 9.1 (2.8–23) | <0.0005 | ||||
Atrial fibrillation | 4.3 (0.9–13) | <0.05 |
Hb: Hemoglobin; HbSS: Sickle cell anemia; NC: Not calculated; RBC: Red blood cell.